These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 7501353

  • 1. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA, Caspers DR, Cohen GR, Zucker ML, Strope BD, McKenzie DR.
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [Abstract] [Full Text] [Related]

  • 2. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
    Liu J, Wang Q, Gao F, He JW, Zhao JH.
    J Perinat Med; 2006 Dec; 34(2):173-6. PubMed ID: 16519625
    [Abstract] [Full Text] [Related]

  • 3. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation.
    Thorp JA, Ferrette-Smith D, Gaston LA, Johnson J, Yeast JD, Meyer B.
    Obstet Gynecol; 1995 Jul; 86(1):1-8. PubMed ID: 7784000
    [Abstract] [Full Text] [Related]

  • 4. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants.
    Kazzi NJ, Ilagan NB, Liang KC, Kazzi GM, Poland RL, Grietsell LA, Fujii Y, Brans YW.
    Pediatrics; 1989 Dec; 84(6):1045-50. PubMed ID: 2587133
    [Abstract] [Full Text] [Related]

  • 5. Maternally administered antenatal vitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage.
    Pomerance JJ, Teal JG, Gogolok JF, Brown S, Stewart ME.
    Obstet Gynecol; 1987 Aug; 70(2):235-41. PubMed ID: 3601288
    [Abstract] [Full Text] [Related]

  • 6. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial.
    Thorp JA, Parriott J, Ferrette-Smith D, Meyer BA, Cohen GR, Johnson J.
    Obstet Gynecol; 1994 Jan; 83(1):70-6. PubMed ID: 8272312
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Coagulation studies in very low-birthweight infants.
    Seguin JH, Topper WH.
    Am J Perinatol; 1994 Jan; 11(1):27-9. PubMed ID: 8155205
    [Abstract] [Full Text] [Related]

  • 9. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation.
    Liu J, Wang Q, Zhao JH, Chen YH, Qin GL.
    J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G.
    Z Kinderheilkd; 1967 Oct; 101(3):230-41. PubMed ID: 5626847
    [No Abstract] [Full Text] [Related]

  • 12. Maternal-fetal transport of vitamin K1 and its effects on coagulation in premature infants.
    Yang YM, Simon N, Maertens P, Brigham S, Liu P.
    J Pediatr; 1989 Dec; 115(6):1009-13. PubMed ID: 2585215
    [Abstract] [Full Text] [Related]

  • 13. Effects of preeclampsia on maternal and cord blood clotting activity.
    Lox CD, Word RA, Corrigan JJ.
    Am J Perinatol; 1985 Oct; 2(4):279-82. PubMed ID: 4052178
    [Abstract] [Full Text] [Related]

  • 14. [Level of vitamin K-dependent coagulation factors in premature infants and the influence of maternal antenatal administration of vitamin K1 on their activity].
    Liu J, Wang Q, Chen YH, Qin GL, Zhao JH, Zhu LC.
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):908-10. PubMed ID: 16412352
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A, Scandellari R, Scapin M, Vettore S.
    Vitam Horm; 2008 Dec; 78():281-374. PubMed ID: 18374200
    [Abstract] [Full Text] [Related]

  • 17. Vitamin K effect in low birth weight infants.
    Ogata T, Motohara K, Endo F, Kondo Y, Ikeda T, Kudo Y, Iribe K, Matsuda I.
    Pediatrics; 1988 Mar; 81(3):423-7. PubMed ID: 3344186
    [Abstract] [Full Text] [Related]

  • 18. Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit.
    Neary E, Okafor I, Al-Awaysheh F, Kirkham C, Sheehan K, Mooney C, Foran A, Corcoran JD, Ni Ainle F, Cotter M, McCallion N.
    Neonatology; 2013 Mar; 104(3):222-7. PubMed ID: 24030102
    [Abstract] [Full Text] [Related]

  • 19. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
    Arteaga-Vizcaíno M, Espinoza Holguín M, Torres Guerra E, Diez-Ewald M, Quintero J, Vizcaíno G, Estévez J, Fernández N.
    Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
    [Abstract] [Full Text] [Related]

  • 20. Coagulation profile in healthy Nigerian neonates.
    Okunade MA, Essien EM.
    Afr J Med Med Sci; 1998 Oct; 27(1-2):71-2. PubMed ID: 10456134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.